BBMRI-ERIC as a resource for pharmaceutical and life science industries: The development of biobank-based Expert Centres

European Journal of Human Genetics

Volumn 23, Issue 7, 2015, Pages 893-900

  Van Ommen, Gert Jan B ^a   Törnwall, Outi ^b   Bréchot, Christian ^c   Dagher, Georges ^d   Galli, Joakim ^e   Hveem, Kristian ^f   Landegren, Ulf ^e   Luchinat, Claudio ^g   Metspalu, Andres ^h   Nilsson, Cecilia ^e   Solesvik, Ove V ⁱ   Perola, Markus ^b,j   Litton, Jan Eric ^k   Zatloukal, Kurt ^l  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF HELSINKI   (Finland)

^c INSTITUT PASTEUR   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e UPPSALA UNIVERSITY   (Sweden)

^f NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^g UNIVERSITY OF FLORENCE   (Italy)

^h UNIVERSITY OF TARTU   (Estonia)

ⁱ Lifandis AS   (Norway)

^j NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^k Biobanking and BioMolecular Resources Research Infrastructure European Research Infrastructure Consortium   (Austria)

^l MEDICAL UNIVERSITY OF GRAZ   (Austria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOMEDICINE; BIOTECHNOLOGY; COST EFFECTIVENESS ANALYSIS; HEALTH CARE FACILITY; LEGAL ASPECT; MEDICAL EXPERT; NON PROFIT ORGANIZATION; ORGANIZATION AND MANAGEMENT; PATENT; PERSONALIZED MEDICINE; PHARMACEUTICS; PRIORITY JOURNAL; PROPHYLAXIS; PUBLIC-PRIVATE PARTNERSHIP; STANDARDIZATION; SWEDEN; TOTAL QUALITY MANAGEMENT; BIOBANK; DRUG INDUSTRY; ECONOMICS; EUROPE; HUMAN; ORGANIZATION; PROCEDURES; TRANSLATIONAL RESEARCH;

BIOLOGICAL SCIENCE DISCIPLINES; BIOLOGICAL SPECIMEN BANKS; DRUG INDUSTRY; EUROPE; HUMANS; ORGANIZATIONAL OBJECTIVES; PRECISION MEDICINE; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84930867932     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2014.235     Document Type: Article

References (31)

1. 3G: Available at: http://p3g.org (accessed 28 October 2014).
2. Yuille M, Ommen GJ, Bréchot C, et al: Biobanking for Europe. Brief Bioinform 2007; 9: 14-24.
3. BBMRI-ERIC: Available at: http://www.bbmri-eric.eu/web/guest/nodes (accessed 28 October 2014).
4. Reichel J, Lind A, Hansson MG, Litton J: ERIC: a new governance tool for biobanking. Eur J Hum Genet 2014; 22: 1055-1057.
5. ESFRI Roadmap for Research Infrastructures, Update 2008.
6. Zatloukal K, Hainaut P: Human tissue biobanks as instruments for drug discovery and development: impact on personalized medicine. Biomarkers Med 2010; 4: 895-903.
7. BCC Market Research: Biomarkers 2007 and 2011: Available on BCC's webpages at: http://www.bccresearch.com/market-research/biotechnology/biomarkers-market-bio 061a.html and http://www.bccresearch.com/market-research/biotechnology/biomakers-technologies-markets-bio061b.html (accessed 28 October 2014).
8. BCC Market Research: Cancer Profiling and Pathways 2014: Available on BCC's webpage at: http://www.bccresearch.com/market-research/biotechnology/cancer-profiling-pathways-bio073b.html (accessed 28 October 2014).
9. Biomarkers-Advanced Technologies and Global Market (2009-2014): Available at: http://www.reportlinker.com/p0148006-summary/Biomarkers-Advanced-Technologies-and-Global-Market.html (accessed 24 August 2014).
10. News on signed cooperation between the University of Tartu and Nestlé Institute of Health Sciences: Available on University's webpage at: https://www.ut.ee/en/news/university-tartu-and-nestle-institute-health-sciences-signed-cooperation-agreement (accessed 28 October 2014).
11. Amihy Pharmacy News' raport on Global Market for Molecular Diagnostics 2011: Available on Amihy Pharmacy News on webpage at: http://amihy.com/?p =7 (accessed 24 August 2014).
12. BCC Market Research: Bioinformatics 2013: Available on BCC's webpage at: http://www.bccresearch.com/market-research/biotechnology/bioinformatics-market-technology-bio051b.html (accessed 28 October 2014).
13. Pharma IQ: The Bioinformatics Market is Poised for Growth 2013: Available at: http://www.pharma-iq.com/informatics/articles/the-bioinformatics-market-is-poised-for-growth/(accessed 28 October 2014).
14. Dibyajyoti S, Bin ET, Swati P: Bioinformatics: the effects on the cost of drug discovery. Galle Med J 2013; 18: 44-50.
15. Bioinformatics and Drug Discovery: Benefits of Bioinformatics Technology in Drug Discovery 2005: Available at: http://bioinformaticsanddrugdiscovery.blogspot.nl/(accessed 28 October 2014).
16. DiMasi JA, Hansen RW, Grabowski HG: The price of innovation: new estimates of drug development costs. J Health Econ 2003; 22: 151-185.
17. The Innovative Medicines Initiative: Assessment of Economical and Societal Effects 2007: Available on IMI's webpage at: http://www.imi.europa.eu/sites/default/files/uploads/documents/imi-ia-report-032007-en.pdf (accessed 28 October 2014).
18. Qabaja A, Alshalalfa M, Alanazi E, Alhajj R: Prediction of novel drug indications using network driven biological data prioritization and integration. J Cheminform 2014; 6: 1.
19. Simeon-Dubach D, Burt AD, Hall PA: Journal of Pathology Editorial: quality really matters: the need to improve specimen quality in biomedical research. J Pathol 2012; 228: 431-433.
20. Metzker ML: Sequencing technologies-the next generation. Nat Rev Genet 2010; 11: 31-46.
21. Protection of Human Rights and Dignity Treaty 1997: Available on Council of Europe's webpage at: http://conventions.coe.int/Treaty/Commun/QueVoulezVous.asp? CL=ENG&NT =164 (accessed 28 October 2014).
22. Nature Editorial: Biobanks need pharma. Nature 2009; 461: 448.
23. Gaskell G, Gottweis H: Biobanks need Publicity. Nature 2011; 471: 161-162.
24. Sathar MA, Dhai A: Laws, regulations and guidelines of developed countries, developing countries in Africa, and BRICS regions pertaining to the use of human biological material (HBM) in research. S Afr J Bioethics Law 2012; 5: 51-54.
25. Hansson MG, van Ommen GJ, Chadwick R, Dillner J: Patients would benefit from simplified ethical review and consent procedure. Lancet Oncol 2013; 14 (6): 451-453.
26. Wellcome Trust, UK: Available at: http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy-communications/documents/web-document/wtvm054713.pdf (accessed 24 August 2014).
27. TMF, DE: Available at: http://www.tmf-ev.de/Desktopmodules/Bring2Mind/DMX/Download.aspx?EntryId =25101&PortalId=0 (accessed 24 August 2014).
28. Science for Life Laboratory: Available at: http://www.scilifelab.se (accessed 28 October 2014).
29. BARCdb: Available at: http://www.barcdb.org (accessed 28 October 2014).
30. Lifandis AS: Available at: http://www.lifandis.com (accessed 28 October 2014).
31. The Estonian Genome Center: Available at: http://www.biobank.ee (accessed 28 October 2014).